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The effects of the hypoglycemic sulfonylureas tolbutamide and glibenclamide on free cytoplasmic Ca2+, 
[Ca2+],, were compared with that of a depolarizing concentration f K+ in dispered and cultured pancreatic 
/I-celIs from ob/ob mice. [Ca2+], was measured with the fluorescent Ca2+ -indicator quin2. The basal evel 
corresponded to 150 nM and increased to600 nM after exposure to 30.9 mM K+. The corresponding levels 
after striation with 1 FM gli~cla~de and 100 FM tolbut~ide were 390 and 270 nM respectively. K+ 
depolarization i creased [Ca2+]l more rapidly than either of the sulfonylureas. It is suggested that the 
increased [Ca2+], obtained after stimulation by sulfonylureas is due to depolarization f the /?-cells with sub- 
sequent entry of Ca2+ through voltage-dependent channels. 
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1. INTRODUCTION 
It is well established that the insulin release 
evoked by hypoglycemic sulfonylureas is depen- 
dent upon adequate concentrations of extracellular 
Ca2+ [I]. Furthermore, it has been demonstrated 
that these drugs promote Ca2+ influx into the pan- 
creatic &?-cells, an effect probably due to depolari- 
zation with subsequent opening of voltage-depen- 
dent Ca2+ channels f2-51. The action of sulfonyl- 
ureas on 4sCa efflux from preloaded islets differed 
from that of glucose in lacking the inhibitory com- 
ponent which is unmasked by lowering the ex- 
tracellular Ca2+ concentration [6]. In a Ca2+-defi- 
cient medium the drugs neither inhibited nor 
stimulated 45Ca efflux [6]. These latter observa- 
tions lend support to the view that the increased 
cytoplasmic Ca2+ concentration, necessary for ac- 
tivation of the insulin secretory machinery after 
sulfonylurea exposure, is promoted by an en- 
hanced membrane permeabi~ty to the ion without 
much involvement of intracellular Ca2+ stores [6]. 
In this communication advantage was taken of 
the fluorescent intracellular Ca2+-indicator quin2 
for direct measurements of free cytoplasmic Ca2+, 
[Ca2+]i, in normal pancreatic ,&cells derived from 
obese-hyperglycemic mice [7- 121. A comparison 
was made between the [Ca2’]i values obtained 
after stimulation by either the hypoglycemic 
sulfonylureas tolbutamide and glibenclamide or 
depolarizing concentrations of K+. 
2. MATERIALS AND METHODS 
All reagents were of analytical grade and redis- 
tilled deionized water was used. Quin21AM and 
the ionophore A23187 were obtained from Cal- 
biochemR (Behring Diagnostics, La Jolla, CA). 
Dimethyl sulfoxide (DMSO) was from Sigma (St. 
Louis, MO). Boehringer Mannheim GmbH 
(Mannheim, FRG) supplied collagenase (EC 
3.4.24.3). Glibenclamide and tolbutamide were 
generous gifts from Hoechst AG (Frankfurt am 
Main, FRG). Tissue culture medium RPMI 1640, 
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bovine fetal serum, penicillin and streptomycin 
were from Gibco, Scotland and gentamicin from 
Essex Chemie AG (Lucerne, Switzerland). 
The experimental medium was a Hepes buffer, 
balanced in cations with Cl- as the sole anion [ 131. 
The Ca2+ concentration was 1.2 mM and the pH 
adjusted to 7.4 with NaOH. To avoid dilution of 
the cell suspension all additions were made from 
concentrated stock solutions. 
The cell aggregates were prepared as described 
by Rorsman et al. [ 121. Adult obese-hyperglycemic 
mice ~o~/o~~ of both sexes were taken from a local 
non-inbred colony f14]. The mice were starved 
overnight and the pancreases were removed im- 
mediately after killing. A collagenase digestion 
technique was used to isolate 500-1000 islets. The 
islets were disrupted gently to obtain a cell suspen- 
sion where the cells remained in pauci-cellular ag- 
gregates [ 151. To remove damaged cells the suspen- 
sion was centrifuged through 10 ml of the basal 
medium supplemented with 4% albumin. The 
pelleted cells were then resuspended in 25 ml of 
RPM1 1640 tissue culture medium cont~ning 10% 
fetal bovine serum, 100 IUlml penicillin, 200 
@g/ml gentamicin and 100 &‘rnl streptomycin. 
This suspension was kept in the tissue culture 
medium for 24-30 h at 37°C and gassed with air 
containing 5% COZ. To prevent attachment of the 
cells to the flask it was gently shaken. In the 
resulting preparation most of the cells were in 
small aggregates. The preparation was routinely 
inspected under phase contrast before loading with 
quinZ/AM. 
QuinZ/AM was added from a 50 mM stock solu- 
tion in DMSO to the tissue culture medium (cell 
density 2-4 x ld cells/ml}, the final concentrations 
of quin%/AM and DMSO in the medium being 50 
FM and O.l%, respectively. After 60 min of 
loading, the cells were centrifuged for 2 min at 
50 x g and washed twice in 10 ml of the incubation 
medium. The cells were then resuspended in 1.25 
ml of the basal incubation medium and transferred 
to the cuvette. Fluorescence was measured in an 
Aminco-Bowman spectrofluorometer with excita- 
tion and emission wavelengths et at 339 and 492 
nm. The instrument was slightly modified to per- 
mit continuous magnetic stirring. All measurements 
were performed at 37% The procedure for 
calibrating the fluorescence signal was the same as 
that previously described by Rorsman and Abra- 
22 
hamsson [1.51. To achieve F,, 10 mM Ca2+ and 20 
mM Tris were added in addition to the 150 nM of 
the ionophore A23187. The autofluorescence was 
assessed by adding l-2 mM Mn2+ to quench quin2 
fluorescence once the F,,,, had been obtained. It 
was ascertained from separate xperiments that the 
background fluorescence was not much altered by 
the various additions. The fluorescence signal was 
also corrected for the presence of extracellular 
quin2; the contribution of which was interpolated 
from measurements at the beginning and end of 
each experiment. The & of the Ca’+-quin complex 
was assumed to be 115 nM 181. Account was also 
taken of photobleaching of the quin2 fluorescence, 
which in separate xperiments was found to be less 
than 10% over 30 min. Intracellular concentra- 
tions of quin2 were calculated using the Fmax value 
as outlined above. The F,, value was compared 
with a calibration curve obtained by adding the 
free acid to the incubation medium. The intracel- 
lular concentration of quin2 was estimated assum- 
ing the&cells to be spheres with a diameter of 13 
pm [16]. Since 1 mg of protein corresponds to 
5 x lo6 cells [17] the intracellular volume can be 
calculated to be 5.5 ,&‘mg protein. The resulting 
intracellular concentration of quin2 is probably an 
underestimate of the actual cytoplasmic concentra- 
tion, since quin2 is not trapped within cellular 
organelles [8]. 
3. RESULTS AND DISCUSSION 
It has been demonstrated that only sulfonylureas 
with insulin releasing activity promote the entry of 
Ca2+ into pancreatic P-cells [18]. Both electro- 
physiological data, revealing depol~ization with 
subsequent appearance of action-potential-like 
spikes, and the rapid initiation of 45Ca uptake, 
decaying with time, support the concept that Ca2+ 
influx is mediated through voltage-dependent 
channels [ 1 g-221. Sulfonylurea-stimulated insulin 
release is therefore believed to be initiated by an in- 
crease in [Ca’+]i although no direct experimental 
data have been available. In the present study ad- 
vantage was taken of the fluorescent Ca2+-indicator 
quin2 [7] for measuring directly changes in [Ca2+]i 
following exposure to s~~fonylureas t concentra- 
tions known to stimulate insulin release. 
AS demonstrated in figs 1 and 2 [Ca’+]i in- 
creased promptly from 147 +5 nM (n=7) to 
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Fig.1. Effects of I(+, D-600, tolbutamide and glibencla- 
mide on intracellular free cytoplasmic Ca2+. Fluorescence 
traces obtained from dispersed and cultured pancreatic 
,&cells loaded with quinf. After loading the ,&cells (2-3 
mg protein) were suspended in 1.25 ml of the basal 
incubation medium. Approximate values of [Ca2+]i as 
well as the effects of K+, D-600, tolbutamide and 
glibenclamide are indicated. 
272 + 52 nM (n = 4) and 386 f 41 nM (n = 3) after 
the addition of 100 PM tolbutamide and 1 PM 
glibenclamide, respectively. In this context it 
should be noted that neither of the additions 
changed the pH of the media. It is evident that 
glibenclamide is more potent than tolbutamide, 
although not as effective as 30.9 mM potassium in 
raising [Ca2’]i. A comparison of [Ca2’]; values 
clearly demonstrated that the subsequent increase 
after exposure to the sulfonylureas was somewhat 
delayed compared to that obtained after stimula- 
tion by high Kf. When discussing differences in 
potency between tolbutamide and glibenclamide it 
should be remembered that the latter drug is excep- 
tional among hypoglycemic sulfonylureas in ac- 
cumulating progressively in the p-cells 1231. The 
discrepancies in [Cazf]i values were not due to dif- 
ferences in intracellular quin2 content, the latter 
corresponding to 2.4kO.4 mM (n =6), 2.5 kO.9 
mM (n=4) and 3.2kO.3 mM (n=3) for K+, 
tolbutamide and glibenclamide, respectively. 
Although it has been suggested that the effect of 
hypo~ycemic sulfonylureas on the &cell handling 
of Ca2+ is mediated by an ionophoretic action of 
the compounds [24-261 convincing arguments 
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Fig.2. Effects of Kf, glibenclamide and tolbutamide on 
intracellular free cytoplasmic Ca”. The [Ca’+]r was 
calculated from experiments like that shown in fig. 1. At 
0 min, K+ (A), glibenclamide (B) or tolbutamide (C) was 
added to the medium. Mean values it SE for 3-7 
experiments. Signi~c~ces for the effects of the various 
additives were calculated using Student’s t-test comparing 
the observed value with that measured immediately 
before the respective additions. “P<O.OZS, bP<O.O1O, 
against this h~othesis have been presented 161. 
This study revealed a similar stimulatory pattern of 
tolbutamide, glibenclamide and high K+ on nor- 
mal pancreatic &cells resulting in increased values 
of [Ca2+]i. Addition of 25 mM K+ to the sulfonyl- 
urea stimulated cells (fig. 1) did not increase [Ca2+]i 
in excess of that obtained with K+ depolarization. 
Furthermore exposure to D-600 immediately 
reduced [Ca”]i to non-stimulatory values inde- 
pendently of whether the P-cells had been stimu- 
lated by high K+ or hypoglycemic sulfonylureas 
(fig. 1). These observations upport the notion that 
hypoglycemic sulfonylureas depolarize the &cells 
and favour the entry of Ca2+ through voltage- 
dependent channels rather than acting as Ca2+ 
ionophores. 
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